ViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

Press/Media: Expert Comment

PeriodJul 8 2020

Media coverage

3

Media coverage

  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletCorporate IT Update
    CountryUnited States
    Date7/8/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang
  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletM2 Pharma
    CountryUnited States
    Date7/8/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang
  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletM2Pharma.com
    CountryUnited States
    Date7/8/20
    URLct.moreover.com/?a=42550361479&p=1gw&v=1&x=YXTv4l0fR0QqPbZ5RTW9WA
    PersonsSlobodan Paessler, John Manning, Cheng Huang

Keywords

  • COVID-19